DBC-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of DBC-2 monoclonal antibodies for research focused on understanding DBC-2's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DBC-2, also known as Deleted in Breast Cancer 2, plays a vital role in regulating apoptosis and cell cycle progression. Research has shown that DBC-2 expression levels correlate with tumorigenesis, highlighting its significance in cancer research. Investigating DBC-2 functions can reveal important insights into cancer development mechanisms. Understanding DBC-2's molecular pathways may lead to innovative therapeutic approaches. Current research indicates that DBC-2 influences multiple cellular pathways involved in cancer progression. Ongoing studies continue to uncover new aspects of DBC-2's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DBC-2's role in cancer biology and potential therapeutic applications.